Polymetal doubles estimates at Russian Albazino project
Precious metals giant Polymetal has announced a significant increase in mineral resources at its Albazino project in the Khabarovsk territory, Russia.
Precious metals giant Polymetal has announced a significant increase in mineral resources at its Albazino project in the Khabarovsk territory, Russia.
The miner said that as of August 1st, mineral resources at Albazino were estimated at 37Mt with an average grade of 4.8g/t of gold (Au) containing 5.7Moz of Au.
The previous estimate was around half this size: as of January 1st, resources were predicted to be 19Mt at 4.5 g/t Au containing 2.8 Moz of Au.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
"Once again, exploration results at Albazino highlight the tremendous potential of this asset and pave the way for the expansion decision to be taken in the second half of 2013," said Vitaly Nesis, Chief Executive Officer of Polymetal.
"Albazino is an excellent example of Polymetal's ability to create value by discovering high-grade ounces close to existing processing facilities".
The company said that active exploration at the site is ongoing with further mineral resource potential identified. In-fill underground drilling in the first half of next year is "expected to lead to a substantial upgrade of inferred resources and allow meaningful resource-to-reserve conversion."
The completion of the optimisation study is expected in the second quarter of 2013.
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
-
GSK share price surges after $2.2bn Zantac drug settlement
GSK has settled lawsuits in the US that alleged the drugmaker’s now-discontinued heartburn drug Zantac triggered cancer
By Chris Newlands Published
-
Will the Autumn Budget impact investment markets?
Keir Starmer has warned the Autumn Budget will be “painful”. Will it impact investment markets and should you tweak your portfolio before 30 October?
By Katie Williams Published